What is the purpose of this trial?
The purpose of this study is to determine the safety, tolerability, and maximum tolerated dose (MTD) of NHS-IL12 when given in combination with a fixed avelumab dose in subjects with metastatic or locally advanced solid tumors.
EMD Serono, Inc.
Dates: 08/11/2017 - 12/01/2018
Last Updated: 08/13/2017
Study HIC#: 2000020301